Seizure

Fang and colleagues invesitgated the association of magnesium levels with posterior reversible encephalopathy syndrome in patients with preeclampsia or eclampsia after 20 weeks of gestation or within 6 weeks postpartum [1]. Their results are consistent with previous studies that hypomagnesemia frequently occurs in the acute phase of obstetric posterior reversible encephalopathy syndrome [2]. Due to the retrospective nature of the study, some concerns may arise.

Levetiracetam (LEV) (Keppra, UCB Pharma-SA, Belgium) is a second-generation broad-spectrum antiepileptic drug (AED) with a favourable pharmacokinetic profile. The lack of effect on cytochrome P450 and its minimal protein binding reduce LEV clinically relevant pharmacokinetic interactions. It is a substrate for multiple efflux transporters, including P-glycoprotein (P-gp/ABCB1).[1,2] Therapeutic drug monitoring (TDM) is increasingly recommended in AED-treated patients, though it is not widely practiced for newer AEDs, including LEV.

Seizure detection devices could be invaluable tools for both people with epilepsy, their caregivers, and clinicians. For patients, having a device that could accurately detect seizures and alert caretakers would help relieve the anxiety from the helplessness that seizures can cause. It could also potentially reduce the risk of sudden unexpected death in epilepsy, particularly for those patients with nocturnal seizures who sleep without a bed partner [1]. For clinicians, seizure detection devices can be an important tool because self-reporting ...

The duration of antiepileptic drug (AED) treatment in the management of seizures due to ring enhancing lesions (REL) remains a matter of debate. We undertook a prospective cohort study to look into the seizure patterns and incidence of recurrence in association with two of the most common causes of RELs after gradually stopping AEDs at least 18 months after acheiving seizure control.

SCN1A variants cause a spectrum of epilepsy syndromes from Dravet Syndrome, a severe epileptic encephalopathy of early infancy to the milder disorder of genetic epilepsy with febrile seizures plus (GEFS+). These genetic epilepsies are associated with increased risk of poor outcome including complications of status epilepticus and early mortality. Individualised management of young children known to be at increased risk should be considered, such as around vaccination management.

This position paper is based on a one-day workshop held in Berlin on October 1st, 2018. The executive board of the German Society of Epileptology (German Chapter of the ILAE; HMH, MH, TM, ASB) invited members of the Federal Joint Committee (G-BA) (see acknowledgement), the Institute for Quality and Efficiency in Health Care (IQWiG) (TK; see acknowledgement) as well as representatives of patient organizations (SF, KR) and drug manufacturers (see acknowledgement) to discuss future designs of trials in adults on ...

Convulsive status epilepticus is the second most common neurologic emergency, with an annual incidence of 10–40 cases per 100,000 people.[1,2] Morbidity and mortality are considerable, and thus, timely termination of convulsive status epilepticus is the primary goal of management to avoid these risks.[3–5] Benzodiazepines, typically lorazepam or diazepam, are used as first-line therapy for status epilepticus.[6–8] After benzodiazepines failed to terminate convulsive status epilepticus in about 40–60% of patients, phenytoin has traditionally been used as a second-stage treatment since the ...

Epilepsy is one of the most common neurological disorders. The unpredictable nature of epileptic seizure attacks may lead to accidental injuries, which can have a negative impact on the quality of life for patients and their caregivers, while also contributing considerably to the burden of the disease. In addition, psychological factors may also have a negative impact on quality of life in PWE 1.

Cerebral venous sinus thrombosis (CVST) is a rare type of cerebrovascular disease, which accounts for only 0.5-1% of all strokes in all age groups (1) and affects mainly young to middle-aged adults (2). The main clinical presentations of CVST include progressive headache, focal neurological deficit, epileptic seizure (ES), and disturbance of consciousness (2).

What impact is there in a story about a single patient? Consider the case of a young reporter who experienced “a month of madness” slightly more than a decade ago that initially defied diagnosis. She was ultimately found to have a newly recognized disease after a series of misdiagnoses said to be “partying too much “and schizoaffective disorder among others following a subacute course of fatigue, numbness in her feet, paranoia, hallucinations and a seizure occurred. In 2009, less than ...